CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 39,876 enrolled
Drug / intervention
Aspirin +2 moredrug
Likely dose
Aspirin 100 mg every other day; Vitamin E 600 IU every other dayAI-extracted
Key inclusion· 3
  • ✓Healthy women
  • ✓No previous history of cardiovascular disease or cancer
  • ✓No contraindications to aspirin or vitamin E
Key exclusion· 0

None specified.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00000479
NCT00000479Phase 3Completed
CompareCT.gov

Women's Health Study of Low-dose Aspirin and Vitamin E in Apparently Healthy Women

Brigham and Women's Hospital·interventional·Posted Oct 28, 1999·Updated Jun 15, 2012

In Brief

A Phase 3 clinical trial evaluating Aspirin, Vitamin E, and 1 other intervention for Cardiovascular Diseases and 6 related conditions. Completed, enrolled 39,876 participants.

Detailed Summary

The purpose of this study is to evaluate the effects of low-dose aspirin and vitamin E in primary prevention of cardiovascular disease and cancer in apparently healthy women.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCardiovascular Diseases, Cerebrovascular Disorders, Coronary Disease, Heart Diseases, Myocardial Infarction, Myocardial Ischemia, Vascular Diseases
Countries--
CollaboratorsNational Cancer Institute (NCI), National Heart, Lung, and Blood Institute (NHLBI)

Timeline

Phase 3CompletedFinished
199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedOct 28, 1999
Enrollment StartSep 1, 1992
Primary CompletionMar 1, 2004
Study CompletionFeb 1, 2005
TodayJul 2, 2026
Enrollment to primary: 11.5 yearsPosted 26.7 years ago

Interventions

Aspirindrug

Participants will receive 100 mg of aspirin every other day.

Vitamin Edrug

Participants will receive 600 IU of vitamin E every other day.

Placebobehavioral

Participants will receive placebo.